Forrestania Resources starts drilling at Lady Lila Project
Forrestania Resources (ASX:FRS) has commenced a diamond drilling program at its Forrestania Hub - Lady Lila Project, marking the first drilling since the granting of mining lease M77/1325.
Every story in this section, newest first — page 273 of 294.
Forrestania Resources (ASX:FRS) has commenced a diamond drilling program at its Forrestania Hub - Lady Lila Project, marking the first drilling since the granting of mining lease M77/1325.
Zeotech (ASX:ZEO) announced the launch of an on-site validation trial of its methane emissions control technology at a North Burnett Regional Council landfill.
Legacy Minerals (ASX:LGM) has launched a 2,000-meter diamond drilling program at its high-priority Mascotte Silver-Gold prospect within the Mt Carrington Project in New South Wales.
More than 544,000 accounts have been removed from Facebook, Instagram, and Threads following Australia's new ban on under-16s using social media.
Osmond Resources (ASX:OSM) has completed a strongly supported share placement, raising $6.6 million to fund its Orión EU Critical Minerals Project.
The Albanese government has announced a $1.2 billion plan to establish a strategic reserve prioritising antimony, gallium, and rare earth elements—minerals crucial for clean-energy technologies, advanced manufacturing, and defence systems.
Electro Optic Systems (ASX:EOS) announced an agreement to acquire MARSS, a Europe-based provider of AI-enabled command and control systems for counter-drone operations.
ReNerve (ASX:RNV), an Australian medical device innovator specialising in peripheral nerve injury solutions, has secured broader listing approval for its NervAlign Nerve Cuff in Hong Kong.
The Singapore International Commercial Court has dismissed in full the Republic of Poland’s application to set aside an Energy Charter Treaty arbitration award in favour of GreenX Metals (ASX:GRX).
WA medicinal cannabis manufacturer Cannaponics is eyeing an Australian Securities Exchange listing in the second half of this year.
Everest Metals (ASX: EMC) and partner MEGA Resources have commenced mining operations at the Mt Dimer Taipan Gold Project.
Imricor Medical Systems (ASX:IMR) announced that the US Food and Drug Administration has granted 510(k) clearance for its Vision-MR Diagnostic Catheter.
Magmatic Resources (ASX:MAG) has commenced a 14-hole, 5,000-metre diamond drilling program at its Myall farm-in and joint venture agreement Copper-Gold Project in New South Wales.
Leeuwin Metals (ASX:LM1) has commenced a major 10,000-metre drilling campaign at its Marda Gold Project near Southern Cross, Western Australia.
FMR Resources (ASX:FMR) has appointed Jack Dowland as CFO, effective immediately.
Global Uranium and Enrichment (ASX:GUE) has announced the completion of its 2025 drill program at the Pine Ridge Uranium Project in Wyoming's Powder River Basin.
Domino's Pizza Enterprises (ASX:DMP) has announced two key senior leadership appointments. Merrill Pereyra has been appointed CEO for Australia and New Zealand, effective Jan. 23.
Coda Minerals (ASX:COD) has resumed its major drilling program at the Elizabeth Creek Copper-Silver Project in South Australia following the holiday break.
Tamboran Resources (ASX:TBN) announced the appointment of Todd Abbott as CEO, effective Jan. 15.
Household spending in Australia remained robust in November 2025, rising 1% from the previous month, the Australian Bureau of Statistics reported.
Nova Eye Medical (ASX:EYE) has reported a record sales performance for the December 2025 quarter, with global revenue reaching US$6.1 million.
Findi (ASX:FND) has announced that its Indian subsidiary, Transaction Solutions International (India) Private, has entered into a binding term sheet with Nova Global Opportunities Fund PCC for a strategic investment of up to 4.18 billion Indian rupees.
CLINUVEL Pharmaceuticals (ASX:CUV) has begun dosing in a preclinical study of its controlled-release injectable peptide platform, VLRX-L.
EBR Systems (ASX:EBR), developer of the world's only wireless cardiac pacing device for heart failure, today reported strong commercial and clinical progress for the quarter ended Dec. 31, 2025.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy